1
|
Zuccarello P, Carnazza G, Salerno M, Esposito M, Cosentino S, Giorlandino A, Sessa F, Pomara C, Barbera N. Forensic investigation on a combined death by food aspiration and acute escitalopram intoxication occurred to a psychiatric subject in a nursing home. Int J Legal Med 2024:10.1007/s00414-024-03168-5. [PMID: 38321300 DOI: 10.1007/s00414-024-03168-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2023] [Accepted: 01/15/2024] [Indexed: 02/08/2024]
Abstract
Food aspiration is one of the major health risks for elderly people in nursing homes which could lead to death. Moreover, misconducts in pharmacotherapy may represent a potential risk of adverse drug reactions. It is reported here the toxicological evaluation of a combined death by food aspiration and acute escitalopram intoxication of a psychiatric subject, occurred in a nursing home. An 89-year-old man, suffering from dysphagia and Alzheimer's, was resident in a nursing home. He was fed with a liquid diet administered directly in mouth using a syringe. The man was also being treated with escitalopram 10 mg tablet. One evening, after receiving the meal in the usual way, the man complained of sudden illness. Carried to the emergency room, the man died about 3 h later with a diagnosis of cardiogenic shock subsequentially to ab ingestis. The histological findings revealed the presence of exogenous material, probably food, up to the finest bronchial branches. The toxicological examination revealed the presence of escitalopram and its main metabolite, desmethylcitalopram: in the blood 1972 ng/ml and 285 ng/ml, in the brain 4657 ng/g and 1025 ng/g, in the gastric content 2317 ng/g and 423 ng/g, in the lung 21,771 ng/g and 468 ng/g, respectively. The bad practice of the nurses to dissolve the escitalopram tablet in the liquefied food and to administer the therapy with a syringe directly into the mouth emerged thanks this investigation. Following food aspiration, escitalopram was absorbed by inhalation route, reaching high concentrations in blood and tissues. The death occurred due to a combined mechanism between food aspiration and the escitalopram toxic action.
Collapse
Affiliation(s)
- P Zuccarello
- Department of Medical, Surgical and Advanced Technologies "G.F. Ingrassia, University of Catania, Catania, Italy.
| | - G Carnazza
- Department of Medical, Surgical and Advanced Technologies "G.F. Ingrassia, University of Catania, Catania, Italy
| | - M Salerno
- Department of Medical, Surgical and Advanced Technologies "G.F. Ingrassia, University of Catania, Catania, Italy
| | - M Esposito
- Department of Medical, Surgical and Advanced Technologies "G.F. Ingrassia, University of Catania, Catania, Italy
| | - S Cosentino
- Department of Pathological Anatomy, A.R.N.A.S. Garibaldi-Nesima, Catania, Italy
| | - A Giorlandino
- Department of Pathological Anatomy, A.R.N.A.S. Garibaldi-Nesima, Catania, Italy
| | - F Sessa
- Department of Medical, Surgical and Advanced Technologies "G.F. Ingrassia, University of Catania, Catania, Italy
| | - C Pomara
- Department of Medical, Surgical and Advanced Technologies "G.F. Ingrassia, University of Catania, Catania, Italy
| | - N Barbera
- Department of Medical, Surgical and Advanced Technologies "G.F. Ingrassia, University of Catania, Catania, Italy
| |
Collapse
|
2
|
Didier HA, Cappellari AM, Sessa F, Giannì AB, Didier AH, Pavesi MM, Caria MP, Curone M, Tullo V, Di Berardino F, Iacona E, Lilli G, Barozzi S, Aldè M, De Bortoli G, Zanetti D, Arnone F, Bussone G. Somatosensory tinnitus and temporomandibular disorders: A common association. J Oral Rehabil 2023; 50:1181-1184. [PMID: 37335244 DOI: 10.1111/joor.13541] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2022] [Revised: 02/16/2023] [Accepted: 06/11/2023] [Indexed: 06/21/2023]
Abstract
BACKGROUND Although the association between tinnitus and temporo-mandibular disorders (TMD) has been frequently reported, their rate of association in the literature shows a great variability. OBJECTIVE We aimed to investigate the prevalence of TMD in patients with somatosensory tinnitus and, vice versa, the occurrence of somatosensory tinnitus in patients with TMD. METHODS The study included patients with somatosensory tinnitus (audiological group) and patients with TMD (stomatological group), evaluated at the audiologic and stomatologic clinics of the Policlinic Hospital of Milan, Italy. Common causes of tinnitus, such as hearing and neurological disorders, were excluded. A cervicogenic somatic tinnitus was also ruled out. Different TMD symptoms, including joint noise and joint pain, were considered. The collected data were analysed using descriptive statistical methods, and the Pearson's Chi-squared test was performed to study the prevalence of the different symptoms by clinical groups. RESULTS Audiological group included 47 patients with somatosensory tinnitus. Overall, TMD was diagnosed in 46 patients (97.8%), including TMJ noise in 37 (78.7%), clenching in 41 (87.2%) and pain in 7 (14.8%) patients. Stomatological group included 50 patients with TMD, including joint noise in 32 (64.0%), clenching in 28 (56.0%) and TMJ pain in 42 (84.0%) patients. A somatosensory tinnitus was diagnosed in 12 (24.0%) patients. CONCLUSION Our study showed a high prevalence of TMD in patients with tinnitus, as well as a not uncommon occurrence of tinnitus in patients presenting with TMD. The distribution of TMD symptoms, such as joint noise, and joint pain was different between the two groups.
Collapse
Affiliation(s)
- H A Didier
- Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy
- Maxillo-Facial Surgery and Dental Unit, Fondazione IRCCS Ca' GrandaOspedale Maggiore Policlinico, Milan, Italy
- Department of Neuroscience, Fondazione IRCCS Ca' GrandaOspedale Maggiore Policlinico, Milan, Italy
- UOC Hospital Pharmacy, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
- Istituto Stomatologico Italiano, Milan, Italy
| | - A M Cappellari
- Department of Neuroscience, Fondazione IRCCS Ca' GrandaOspedale Maggiore Policlinico, Milan, Italy
| | - F Sessa
- Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy
- Maxillo-Facial Surgery and Dental Unit, Fondazione IRCCS Ca' GrandaOspedale Maggiore Policlinico, Milan, Italy
| | - A B Giannì
- Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy
- Maxillo-Facial Surgery and Dental Unit, Fondazione IRCCS Ca' GrandaOspedale Maggiore Policlinico, Milan, Italy
| | - A H Didier
- UOC Hospital Pharmacy, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - M M Pavesi
- Istituto Stomatologico Italiano, Milan, Italy
| | - M P Caria
- CERISMAS (Research Centre in Health Care Management), Catholic University Milan, Milan, Italy
| | - M Curone
- Casa di Cura del Policlinico Igea Headache Center, Milan, Italy
| | - V Tullo
- Casa di Cura del Policlinico Igea Headache Center, Milan, Italy
| | - F Di Berardino
- Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
- Audiology Unit, Department of Specialist Surgical Sciences, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - E Iacona
- Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
| | - G Lilli
- Casa di Cura del Policlinico Igea Headache Center, Milan, Italy
| | - S Barozzi
- Casa di Cura del Policlinico Igea Headache Center, Milan, Italy
| | - M Aldè
- Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
| | - G De Bortoli
- Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
| | - D Zanetti
- Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
- Audiology Unit, Department of Specialist Surgical Sciences, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - F Arnone
- Azienda Ospedaliera Santi Paolo e Carlo, Milan, Italy
| | - G Bussone
- Casa di Cura del Policlinico Igea Headache Center, Milan, Italy
| |
Collapse
|
3
|
Mariotti A, Spatafora P, Sessa F, Saieva C, Galli IC, Roviello G, Doni L, Zaccaro C, Bisegna C, Conte FL, Mariottini R, Marzocco A, Masieri L, Vignolini G, Minervini A, Serni S, Carini M, Nesi G, Villari D. Gender and cystectomy for bladder cancer: A high-volume tertiary urologic care center experience. Eur J Surg Oncol 2023; 49:107034. [PMID: 37639860 DOI: 10.1016/j.ejso.2023.107034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2023] [Revised: 07/23/2023] [Accepted: 08/16/2023] [Indexed: 08/31/2023]
Abstract
BACKGROUND Differences have often been reported in the outcomes of bladder cancer (BC) patients according to gender. OBJECTIVE This study aims to provide data on patients undergoing radical cystectomy (RC) in a high-volume tertiary urologic center and to assess whether gender discrepancies do exist in terms of surgical options and clinical outcomes. MATERIALS AND METHODS Consecutive BC patients treated between 2016 and 2020 at a single center (Careggi University Hospital, Florence, Italy) were included in the study. The impact of gender on disease stage at diagnosis, overall survival (OS), and type of surgery was analyzed. RESULTS The study series comprised 447 patients (85 females and 362 males). At a median follow-up of 28.3 months (IQR: 33.5), OS was 52.6% and cancer-specific survival was 67.6%. Significant differences in OS emerged for age, acute myocardial infarction (AMI), Charlson Comorbidity Index (CCI), pT, and pN. OS rates were higher in patients undergoing robot-assisted surgery and in those receiving open orthotopic neobladder (ONB) (p = 0.0001). No statistically significant differences were found between male and female patients regarding surgical offer in any age group, surgical time, early postoperative complications, pathologic stage, and OS. CONCLUSIONS After adjustment for pathologic tumor stage and treatment modalities, female and male patients showed similar oncologic outcomes. Further studies should be undertaken to evaluate functional results in women subjected to RC.
Collapse
Affiliation(s)
- A Mariotti
- Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.
| | - P Spatafora
- Department of Urology, Careggi Hospital, University of Florence, Florence, Italy
| | - F Sessa
- Department of Urology, Careggi Hospital, University of Florence, Florence, Italy
| | - C Saieva
- Cancer Risk Factors and LifeStyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy
| | - I C Galli
- Histopathology and Molecular Diagnostics, Careggi Hospital, Florence, Italy
| | - G Roviello
- Department of Health Sciences, University of Florence, Florence, Italy
| | - L Doni
- Department of Health Sciences, University of Florence, Florence, Italy
| | - C Zaccaro
- Department of Urology, Careggi Hospital, University of Florence, Florence, Italy
| | - C Bisegna
- Department of Urology, Careggi Hospital, University of Florence, Florence, Italy
| | - F L Conte
- Department of Urology, Careggi Hospital, University of Florence, Florence, Italy
| | - R Mariottini
- Department of Urology, Careggi Hospital, University of Florence, Florence, Italy
| | - A Marzocco
- Department of Urology, Careggi Hospital, University of Florence, Florence, Italy
| | - L Masieri
- Department of Urology, Careggi Hospital, University of Florence, Florence, Italy; Department of Pediatric Surgery, Pediatric Urology Unit, Anna Meyer Children's Hospital, Florence, Italy
| | - G Vignolini
- Department of Urology, Careggi Hospital, University of Florence, Florence, Italy
| | - A Minervini
- Department of Urology, Careggi Hospital, University of Florence, Florence, Italy
| | - S Serni
- Department of Urology, Careggi Hospital, University of Florence, Florence, Italy
| | - M Carini
- Department of Urology, Careggi Hospital, University of Florence, Florence, Italy
| | - G Nesi
- Histopathology and Molecular Diagnostics, Careggi Hospital, Florence, Italy
| | - D Villari
- Department of Urology, Careggi Hospital, University of Florence, Florence, Italy
| |
Collapse
|
4
|
Pecoraro A, Mariotti A, Mariottini R, Mazzola L, Orsini A, Livio V, Firenzuoli N, Nicoletti R, Spatafora P, Facchiano D, Sessa F, Sebastianelli A, Gacci M, Vignolini G, Li Marzi V, Serni S, Campi R. Is it really safe to omit staging chest computed tomography in patients with incidentally diagnosed cT1a renal masses who are candidates for surgery? An audit from a high-volume referral academic centre. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01309-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
5
|
Anceschi U, Amparore D, Siena G, Cocci A, Checcucci E, Prata F, De Cillis S, Flammia R, Tufano A, Quarà A, Ortenzi M, Brassetti A, Bove A, Tuderti G, D’Annunzio S, Viola L, Sessa F, Spatafora P, Fiori C, Varvello F, Minervini A, Ferrari G, Porpiglia F, Cindolo L, Simone G. A novel outcomes categorization for current minimally invasive ejaculation-sparing treatments of benign prostatic hyperplasia: Results of a multicentric series. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00069-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
6
|
Stracci D, Pecoraro A, Catucci C, Gallo M, Firenzuoli N, Spatafora P, Facchiano D, Sessa F, Tuccio A, Sebastianelli A, Giancane S, Gacci M, Vignolini G, Li Marzi V, Serni S, Campi R. Robot-assisted living donor nephrectomy: Toward a new standard? Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01344-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
7
|
Pecoraro A, Li Marzi V, Sessa F, Boissier R, Hevia V, Prudhomme T, Andras I, Breda A, Serni S, Territo A, Campi R. Role of European urologists in kidney transplantation: An EAU-YAU kidney transplantation working group survey. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00450-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
8
|
Sessa F, Rivetti A, Polverino P, Lo Re M, Bisegna C, Saladino M, Siena G, Cocci A, Pecoraro A, Campi R, Minervini A, Serni S. Ejaculation preservation in patients with benign prostatic obstruction: The safety and efficacy of transperineal interstitial laser ablation. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00066-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
9
|
Antonelli A, Cindolo L, Sandri M, Veccia A, Annino F, Bertagna F, Di Maida F, Celia A, D’Orta C, De Concilio B, Furlan M, Giommoni V, Ingrosso M, Mari A, Nucciotti R, Olianti C, Porreca A, Primiceri G, Schips L, Sessa F, Bove P, Simeone C, Minervini A. The role of warm ischemia time on functional outcomes after robotic partial nephrectomy: Data from the clock randomized trial. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01068-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
10
|
Stracci D, Gallo M, Pecoraro A, Mariotti A, Stracci D, Marzocco A, Livio V, Mazzola L, Dibilio E, Polverino P, Nicoletti R, Lo Re M, Conte F, Alberti A, Sessa F, Giancane S, Vignolini G, Gacci M, Serni S, Campi R. Assessing the intraoperative morbidity of kidney cancer surgery for organ-confined (CT1-T2N0M0) renal masses at a high-volume centre: the value of the eau intraoperative adverse incident classification for standardized reporting. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01298-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
11
|
Mariotti A, Pecoraro A, Stracci D, Gallo M, Marzocco A, Valeria L, Mazzola L, Dibilio E, Polverino P, Nicoletti R, Re ML, Conte F, Alberti A, Sessa F, Sebastianelli A, Gacci M, Serni S, Campi R. Translating the results of the keynote-564 trial to clinical practice: characteristics and outcomes of patients with clear-cell non-metastatic renal cell carcinoma (RCC) who may potentially benefit from adjuvant pembrolizumab after surgery at a referral academic centre. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01301-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
12
|
Gandaglia G, Mazzone E, Ploussard G, Marra G, Valerio M, Campi R, Mari A, Minervini A, Serni S, Moschini M, Marquis A, Beauval J, Rakauskas A, Sessa F, van den Bergh R, Rahota R, Soeterik T, Roumiguiè M, Afferi L, Zhuang J, Guo H, Mattei A, Gontero P, Cucchiara V, Stabile A, Fossati N, Montorsi F, Briganti A. Outcomes of prostate cancer patients with seminal vesicle invasion at multiparametric MRI managed with radical prostatectomy. Do all patients really need for a multi-modal approach? EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01240-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
13
|
Gallo M, Barzaghi P, Mariotti A, Pecoraro A, Stracci D, Marzocco A, Livio V, Mazzola L, Dibilio E, Polverino P, Nicoletti R, Re ML, Conte F, Alberti A, Sessa F, Giancane S, Spatafora P, Gacci M, Serni S, Campi R. Contemporary techniques and outcomes of surgery for locally advanced renal cell carcinoma at a referral academic centre: the value of a multidisciplinary team. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01300-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
14
|
Mariotti A, Pecoraro A, Stracci D, Gallo M, Marzocco A, Livio V, Mazzola L, Dibilio E, Polverino P, Nicoletti R, Re ML, Conte F, Alberti A, Sessa F, Spatafora P, Facchiano D, Gacci M, Serni S, Campi R. Could preoperative 99mTc-sestamibi spect/ct improve decision-making in patients with cT1 renal masses? EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01299-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
15
|
Gandaglia G, Mazzone E, Ploussard G, Marra G, Valerio M, Campi R, Mari A, Minervini A, Serni S, Moschini M, Marquis A, Beauval JB, Rakauskas A, Sessa F, Van Den Bergh R, Rahota RG, Soeterik T, Roumiguié M, Afferi L, Zhuang J, Guo H, Mattei A, Gontero P, Montorsi F, Briganti A. Definition and predictors of upgrading at final pathology in prostate cancer patients undergoing mri-targeted and systematic biopsies: Results from a large, multi-institutional series. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00700-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
16
|
Campi R, Pecoraro A, Sessa F, Barzaghi P, Rivetti A, Nicoletti R, Gallo M, Corti F, Morselli S, Spatafora P, Gacci M, Giancane S, Sebastianelli A, Cirami L, Peris A, Vignolini G, Serni S, Li Marzi V. Perioperative and functional outcomes after kidney transplantation from uncontrolled donors after circulatory death vs. expanded-criteria donors after brain death vs. standard-criteria donors: Toward an evidence-based refinement of allocation strategies. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01177-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Campi R, Pecoraro A, Li Marzi V, Tuccio A, Barzaghi P, Corti F, Rivetti A, Nicoletti R, Gacci M, Morselli S, Sebastianelli A, Sessa F, Spatafora P, Giancane S, Peris A, Cirami C, Breda A, Vignolini G, Serni S. Robotic versus open kidney transplantation from deceased donors: The first prospective observational study. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01171-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
18
|
Bisegna C, Sessa F, Campi R, Rivetti A, Gallo M, Barzaghi P, Vittori G, Tuccio A, Polverino P, Spatafora P, Minervini A, Carini M, Serni S. Transperineal interstitial Laser Ablation (TPLA) of the prostate for selected patients with benign prostatic obstruction: Step-by-step technique and preliminary findings. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01280-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
19
|
Pecoraro A, Rivetti A, Sessa F, Barzaghi P, Corti F, Morselli S, Ferretti R, Garcia J, Freso A, Berni A, Nicoletti R, Giancane S, Gacci M, Li Marzi V, Sebastianelli A, Vignolini G, Serni S, Campi R. Rate and predictors of benign pathology after surgery for localized (cT1N0M0) renal masses at a high-volume academic centre: implications for selection of renal biopsy candidates. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)01001-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
20
|
Presutti M, Sessa F, Vittori G, Mari A, Campi R, Bisegna C, Polverino P, Di Maida F, Minervini A, Serni S, Carini M. High intensity focused ultrasound (HIFU) for treatment of localized prostate cancer: high-volume single-center experience. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)01008-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
21
|
Grosso A, Tellini R, Verrienti P, Salvi M, Sessa F, Campi R, Di Maida F, Di Camillo M, Lambertini L, Mormile N, Nardoni S, Olivera L, Valastro F, Cangemi V, Viola L, Scelzi S, Mari A, Masieri L, Carini M, Minervini A, Tuccio A. Predictors of early catheter replacement after HoLEP: results from a high-volume laser center. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00799-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
22
|
Serni S, Pecoraro A, Rivetti A, Sessa F, Barzaghi P, Corti F, Caneschi C, Santalmasi C, Paganelli D, Basilico V, Morselli S, Nicoletti R, Giancane S, Spatafora P, Gacci M, Li Marzi V, Sebastianelli A, Vignolini G, Campi R. Assessing the intra- and postoperative morbidity of kidney cancer surgery for organ-confined (cT1-T2N0M0) renal masses according to the eau quality criteria for standardized reporting: a prospective single-centre study. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00999-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
23
|
Bove P, Bertolo R, Sandri M, Cindolo L, Annino F, Cipriani C, Leonardo C, Parma P, Nucciotti R, Porreca A, Falsaperla M, Veneziano D, Celia A, Veccia A, Veccia A, Sessa F, Mari A, Minervini A, Antonelli A. Cross-analysis of two randomized trials to compare pure versus robot-assisted off-clamp laparoscopic partial nephrectomy. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00956-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
24
|
Cocci A, Russo G, Sessa F, Tuccio A, Masieri L, Sforza S, Viola L, Cito G, Salamanca JM, Cindolo L, Ferrari G, Siena G. Functional and sexual symptoms improvement after Rezum water vapor therapy for the treatment of LUTS/BPE: 1-year results from a longitudinal multi-center italian study. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00882-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
25
|
Campi R, Pecoraro A, Sessa F, Barzaghi P, Corti F, Morselli S, Rivetti A, Nicoletti R, Giancane S, Spatafora P, Tuccio A, Gacci M, Li Marzi V, Sebastianelli A, Vignolini G, Serni S. Is robotic kidney transplantation non-inferior to open kidney transplantation in the setting of deceased donors? A single-centre preliminary experience. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00835-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
26
|
Luongo C, Morra R, Gambale C, Porcelli T, Sessa F, Matano E, Damiano V, Klain M, Schlumberger M, Salvatore D. Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy. J Endocrinol Invest 2021; 44:1927-1933. [PMID: 33576954 PMCID: PMC8357750 DOI: 10.1007/s40618-021-01508-5] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/03/2020] [Accepted: 01/10/2021] [Indexed: 12/13/2022]
Abstract
BACKGROUND AND PURPOSE Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that enhance the immune response against cancer cells. ICIs are generally well tolerated, although endocrine immune-related adverse events (irAEs) are common. We investigated the risk factors for thyroid irAEs in patients treated with ICIs. Moreover, we evaluated the clinical outcome of subjects who became hypothyroid compared to euthyroid patients. PATIENTS AND METHODS We retrospectively analyzed a series of 195 consecutively subjects treated with ICIs for metastatic tumors at the University of Naples "Federico II" between January 2014 and March 2020. Only subjects tested for thyroid function before and during the treatment with ICIs were included. RESULTS In the 96 patients treated with ICIs who were included [66 males, median age: 62 years (27-87)], thyroid irAEs occurred in 36 (37.5%), 16 (16.7%) a transient thyrotoxicosis, and 20 (20.8%) an hypothyroidism (in nine subjects hypothyroidism was preceded by a transient thyrotoxicosis). Only baseline TSH levels above 1.67 mIU/L and positive anti-thyroid antibodies (Ab-T) were associated with a higher risk of hypothyroidism. Patients with hypothyroidism during ICI treatment showed an improved 2-year PFS (HR = 0.82 CI 0.47-1.43; p = 0.0132) and OS (HR = 0.38 CI 95% 0.17-0.80; p = 0.011) compared to euthyroid patients. CONCLUSIONS Baseline TSH levels above 1.67 mIU/L and presence of Ab-T are risk factors for the development of thyroid irAEs. Patients affected by thyroid irAEs showed a longer survival than patients who remained euthyroid.
Collapse
Affiliation(s)
- C Luongo
- Department of Public Health, University of Naples "Federico II", Via S Pansini, 5, 80131, Naples, Italy.
| | - R Morra
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy
| | - C Gambale
- Department of Public Health, University of Naples "Federico II", Via S Pansini, 5, 80131, Naples, Italy
| | - T Porcelli
- Department of Public Health, University of Naples "Federico II", Via S Pansini, 5, 80131, Naples, Italy
| | - F Sessa
- Department of Public Health, University of Naples "Federico II", Via S Pansini, 5, 80131, Naples, Italy
| | - E Matano
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy
| | - V Damiano
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy
| | - M Klain
- Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy
| | - M Schlumberger
- Department of Endocrine Oncology, Gustave Roussy, University Paris-Saclay, 94805, Villejuif, France
| | - D Salvatore
- Department of Public Health, University of Naples "Federico II", Via S Pansini, 5, 80131, Naples, Italy.
| |
Collapse
|
27
|
Sessa F, Veeyee KF, Canu P. Optimization of biochar quality and yield from tropical timber industry wastes. Waste Manag 2021; 131:341-349. [PMID: 34229232 DOI: 10.1016/j.wasman.2021.06.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/07/2021] [Revised: 06/20/2021] [Accepted: 06/21/2021] [Indexed: 06/13/2023]
Abstract
The conversion of timber industry waste to biochar was investigated, based on residues from local tropical hardwoods in Cameroon. Closed and flow reactors, loaded with few grams of the sample and fluxed with different inert gases, were used with the aim of converting these wood residues to a safe and efficient solid fuel that can be exploited by the local community for cooking purposes. The pyrolysis temperature had the highest impact on the process up to approximately 700 °C as biochar yields decreased from 87 to 23.5% while increasing the temperature. A significant concentration of carbon required temperatures greater than 500 °C for the biochar to become a good solid fuel, approaching the heating value of coal. The role of heating rate appeared marginal even in a broad range: 0.1 to 70 °C/min. The dwell time (in the range 0.5 to 5 h) at maximum temperature revealed to be of little influence on the charring which occurred mostly during the first few minutes of the isothermal phase. Thus, actual production time can be <1 h/batch (up to 500 °C at 10 °C/min). Stepwise heating revealed a sequence of devolatilization reactions following their activation energies. Use of CO2 as inert gas increased the char yield. The inert gas flow rate had two contrasting effects on the biochar yield, in relation to volatile components residence time and the biomass temperature. The reactivity of biochar in combustion suggests a trade-off between heating content and reactivity. Charring in a closed, pressurized reactor produced biochar of low value as fuel, with tars absorbed in the porous solid residue.
Collapse
Affiliation(s)
- F Sessa
- University of Padova, Department of Industrial Engineering, Via Marzolo 9, 35131 Padova, Italy
| | - K F Veeyee
- Department of Environmental Engineering, National Advanced School of Public Works, Yaounde, Cameroon
| | - P Canu
- University of Padova, Department of Industrial Engineering, Via Marzolo 9, 35131 Padova, Italy.
| |
Collapse
|
28
|
Campi R, Vignolini G, Pecoraro A, Morselli S, Nicoletti R, Rivetti A, Berni A, Paganelli D, Sessa F, Greco I, Corti F, Mormile N, Barzaghi P, Gianassi J, Cutruzzullà R, Spatafora P, Sebastianelli A, Giancane S, Li Marzi V, Gacci M, Cirami C, Serni S. Four-year experience with robotic kidney transplantation from deceased donors: Overcoming logistical and technical challenges to broaden the indications of robotic kidney transplantation. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)00731-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
29
|
Campi R, Pecoraro A, Sessa F, Morselli S, Gemma L, Greco I, Barzaghi P, Grosso A, Corti F, Mormile N, Spatafora P, Caroassai S, Berni A, Caneschi C, Gacci M, Giancane S, Sebastianelli A, Li Marzi V, Vignolini G, Serni S. Robot-assisted laparoscopic living donor nephrectomy: The university of Florence technique. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01662-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
30
|
Leoni E, Cerati M, Finzi G, Lombardo M, Sessa F. COVID-19 and HHV8 first spotted together: an affair under electron microscopy. J Eur Acad Dermatol Venereol 2021; 35:e311-e312. [PMID: 33460479 PMCID: PMC8013213 DOI: 10.1111/jdv.17123] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- E Leoni
- Unit of Pathology, Department of Medicine and Surgery, University of Insubria, Varese, Italy
| | - M Cerati
- Department of Pathology, ASST Sette Laghi, Varese, Italy
| | - G Finzi
- Department of Pathology, ASST Sette Laghi, Varese, Italy
| | - M Lombardo
- Department of Dermatology, ASST Sette Laghi, Varese, Italy
| | - F Sessa
- Unit of Pathology, Department of Medicine and Surgery, University of Insubria, Varese, Italy.,Department of Pathology, ASST Sette Laghi, Varese, Italy
| |
Collapse
|
31
|
Abstract
The diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection relies on the detection of viral RNA by real-time reverse transcription polymerase chain reaction (rRT-PCR) performed with respiratory specimens, especially nasopharyngeal swabs. However, this procedure requires specialized medical personnel, centralized laboratory facilities, and time to provide results (from several hours up to 1 d). In addition, there is a non-negligible risk of viral transmission for the operator who performs the procedure. For these reasons, several studies have suggested the use of other body fluids, including saliva, for the detection of SARS-CoV-2. The use of saliva as a diagnostic specimen has numerous advantages: it is easily self-collected by the patient with almost no discomfort, it does not require specialized health care personnel for its management, and it reduces the risks for the operator. In the past few months, several scientific papers, media, and companies have announced the development of new salivary tests to detect SARS-CoV-2 infection. Posterior oropharyngeal saliva should be distinguished from oral saliva, since the former is a part of respiratory secretions, while the latter is produced by the salivary glands, which are outside the respiratory tract. Saliva can be analyzed through standard (rRT-PCR) or rapid molecular biology tests (direct rRT-PCR without extraction), although, in a hospital setting, these procedures may be performed only in addition to nasopharyngeal swabs to minimize the incidence of false-negative results. Conversely, the promising role of saliva in the diagnosis of SARS-CoV-2 infection is highlighted by the emergence of point-of-care technologies and, most important, point-of-need devices. Indeed, these devices can be directly used in workplaces, airports, schools, cinemas, and shopping centers. An example is the recently described Rapid Salivary Test, an antigen test based on the lateral flow assay, which detects the presence of the virus by identifying the spike protein in the saliva within a few minutes.
Collapse
Affiliation(s)
- L. Azzi
- Unit of Oral Medicine and
Pathology, ASST dei Sette Laghi–Ospedale di Circolo e Fondazione Macchi,
Department of Medicine and Surgery, University of Insubria, Varese,
Italy
| | - V. Maurino
- Unit of Oral Medicine and
Pathology, ASST dei Sette Laghi–Ospedale di Circolo e Fondazione Macchi,
Department of Medicine and Surgery, University of Insubria, Varese,
Italy
| | - A. Baj
- Laboratory of Clinical
Microbiology, ASST dei Sette Laghi–Ospedale di Circolo e Fondazione Macchi,
Department of Medicine and Surgery, University of Insubria, Varese,
Italy
| | - M. Dani
- Unit of Oral Medicine and
Pathology, ASST dei Sette Laghi–Ospedale di Circolo e Fondazione Macchi,
Department of Medicine and Surgery, University of Insubria, Varese,
Italy
| | - A. d’Aiuto
- Unit of Oral Medicine and
Pathology, ASST dei Sette Laghi–Ospedale di Circolo e Fondazione Macchi,
Department of Medicine and Surgery, University of Insubria, Varese,
Italy
| | - M. Fasano
- Laboratory of Biochemistry and
Functional Proteomics, Department of Science and High Technology, Busto
Arsizio (VA), Italy
| | - M. Lualdi
- Laboratory of Biochemistry and
Functional Proteomics, Department of Science and High Technology, Busto
Arsizio (VA), Italy
| | - F. Sessa
- Unit of Pathology, ASST dei Sette
Laghi–Ospedale di Circolo e Fondazione Macchi, Department of Medicine and
Surgery, University of Insubria, Varese, Italy
| | - T. Alberio
- Laboratory of Biochemistry and
Functional Proteomics, Department of Science and High Technology, Busto
Arsizio (VA), Italy
| |
Collapse
|
32
|
Sessa F, Tellini R, Grosso A, Salvi M, Campi R, Verrienti P, Matteo D, Viola L, Di Maida F, Scelzi S, Mari A, Carini M, Minervini A, Tuccio A. Patterns and predictors of optimal surgical and functional outcomes after holmium laser enucleation of the prostate (HoLEP): introducing the concept of “trifecta”. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35444-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
33
|
Greco I, Pecoraro A, Gemma L, Sessa F, Grosso A, Barzaghi P, Corti F, Mormile N, Grisanti S, Giancane S, Tuccio A, Gacci M, Li Marzi V, Sebastianelli A, Vignolini G, Serni S, Campi R. Perioperative and functional outcomes after robotic vs open kidney transplantation using grafts from donors after brain death: preliminary experience. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35472-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
34
|
Vignolini G, Campi R, Sessa F, Gemma L, Greco I, Pecoraro A, Barzaghi P, Corti F, Giancane S, Li Marzi V, Sebastianelli A, Gacci M, Serni S. Robotic radical cystectomy with open-assisted hybrid orthotopic ileal neobladder: a prospective single-centre study (IDEAL phase 2a). EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35593-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
35
|
Tuccio A, Grosso A, Salvi M, Sessa F, Tellini R, Viola L, Bisegna C, Di Camillo M, Verrienti P, Di Maida F, Mari A, Scelzi S, Crisci A, Carini M, Minervini A. En-bloc’ HoLEP with early apical release: are we ready for a new paradigm? EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35452-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
36
|
Serni S, Campi R, Greco I, Pecoraro A, Sessa F, Manetti C, Dattolo F, Mascherini J, Gemma L, Grosso A, Barzaghi P, Corti F, Mormile N, Grisanti S, Giancane S, Tuccio A, Gacci M, Li Marzi V, Sebastianelli A, Vignolini G. Robotic living donor nephrectomy: our 10-year experience. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35471-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
37
|
Cindolo L, De Nunzio C, Lombardo R, Bertolo R, Bove P, Minervini A, Sessa F, Muto G, Vittori M, Bozzini G, Castellan P, Mugavero F, Falsaperla M, Schips L, Celia A, Bada M, Porreca A, Pastore A, Al Salhi Y, Giampaoli M, Novella G, Rizzetto R, Trabacchin N, Mantica G, Antonelli A, Pini G, Remmers S, Tubaro A. Rotterdam mobile phone appincluding MRI data for the prediction of prostate cancer: A multicenter external validation. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35354-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
38
|
Li Marzi V, Campi R, Pecoraro A, Greco I, Gemma L, Sessa F, Giancane S, Tuccio A, Gacci M, Sebastianelli A, Lazzeri C, Vignolini G, Cirami C, Migliaccio M, Peris A, Serni S. Perioperative and functional outcomes after kidney transplantation from uncontrolled donors after circulatory death (UDCD) vs extended criteria donors after brain death (eDBD): A single-centre experience. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35475-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
39
|
Campi R, Greco I, Sessa F, Giancane S, Sebastianelli A, Gacci M, Li Marzi V, Serni S, Vignolini G. Implementation of a robotic kidney transplantation program from living and deceased donors in a referral academic centre: 3-year experience. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33560-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
40
|
Abrate A, Sessa F, Sessa M, Campi R, Sebastianelli A, Preto M, Olivero A, Varca V, Benelli A, Pavone C, Serretta V, Vella M, Brunocilla E, Serni S, Trombetta C, Terrone C, Gregori A, Lissiani A, Gontero P, Schiavina R, Gacci M, Simonato A. Segmental ureterectomy vs radical nephroureterectomy in elderly patients treated for upper tract urothelial carcinoma. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33732-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
41
|
Grosso A, Bianchi L, Sessa F, Di Camillo M, Salvi M, Viola L, Tellini R, Campi R, Borghesi M, Dababneh H, Brunocilla E, Carini M, Minervini A, Schiavina R, Tuccio A. Is holmium laser enucleation of the prostate (HoLEP) safe and effective in patients with a high comorbidity burden? Insights from two referral academic centres. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)34062-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
42
|
Piantanida E, Gallo D, Dozio E, Trotti E, Piantanida E, Frattini F, Franzi F, Sessa F, Dionigi GL, Sabatino J, Bartalena L, Tanda ML, Ippolito S. Gastric Xanthomatous Hyperplastic Polyps – Just an Incidental Endoscopic Finding? Surg Case Rep 2020. [DOI: 10.31487/j.scr.2020.05.14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Background: Laparoscopic sleeve gastrectomy (LSG) progressively became the preferred procedure
worldwide for the treatment of morbid obesity. Occasionally, unknown gastrointestinal diseases may be
incidentally discovered during the procedure or on the histologic gastric specimen. Gastric xanthomas are
uncommon lesions of the lamina propria, composed by foamy macrophages and mixed inflammatory
infiltrate. Rarely, xanthoma cells develop within a gastric hyperplastic polyp. Although usually benign, they
may be associated with pre-malignant conditions or even gastric cancer, making advisable an appropriate
workup.
Case Presentation: A hyperplastic polyp with xanthomatous proliferation was discovered in the gastric
specimen of a young man, suffering from severe obesity and metabolic syndrome. The patient had been
treated with proton pump inhibitors for gastric discomfort for years. After the surgical procedure, the gastric
discomfort rapidly disappeared.
Conclusion: Obesity is often complicated by gastrointestinal abnormalities discovered during ultrasound
or endoscopic procedures. Incidental findings of unknown gastric lesions are common occurrences during
sleeve gastrectomy. Although xanthelasmas per se are harmless, they might coexist with pre-malignant/
malignant lesions, especially when associated with gastric polyps. Thus, prompt intra-operative recognition
and adequate work-up are mandatory. Although cases of gastric polyps or xanthomas are not a novelty, to
our knowledge, this is the first case reporting about the discovery of a gastric hyperplastic polyp with
xanthomatous proliferation on gastric histological piece. From the discussion of this case and of similar
reports in the literature, we advocated for the importance of endoscopic screening in obese patients admitted
for bariatric surgery to address the proper surgical approach and follow-up.
Collapse
|
43
|
Ricci C, Righi A, Ambrosi F, Gibertoni D, Maletta F, Uccella S, Sessa F, Asioli S, Pellilli M, Maragliano R, La Rosa S, Papotti MG, Asioli S. Prognostic Impact of MCPyV and TIL Subtyping in Merkel Cell Carcinoma: Evidence from a Large European Cohort of 95 Patients. Endocr Pathol 2020; 31:21-32. [PMID: 31808008 DOI: 10.1007/s12022-019-09601-5] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Merkel cell carcinoma is a rare (∼ 2000 cases/year in the USA) but aggressive neuroendocrine neoplasm of the skin. In 2008, the Merkel cell polyomavirus (MCPyV) was found to be clonally integrated in approximately 80% of Merkel cell carcinomas. The remaining 20% have large numbers of UV-associated mutations. Importantly, both the UV-induced neoantigens in virus-negative Merkel cell carcinoma and the Merkel cell polyomavirus oncogenes that are required for virus-positive tumor growth are highly immunogenic. Indeed, antigen-specific T cells detected in patients are frequently "dysfunctional/exhausted," and the inhibitory ligand PD-L1 is often expressed by Merkel cell carcinoma cells. These data led to point our attention on the quantity and the quality of the immune response in Merkel cell carcinoma. Here, we found CD8+ lymphocytes are the only singly evaluated lymphocyte subclass that strongly influenced overall survival and disease-specific survival in Merkel cell carcinoma. In addition, we highlighted as Merkel cell polyomavirus is a strong prognostic factor and as it prompts a host immune response involving various lymphocyte subclasses (CD3, CD8, FoxP3, and PD-L1 positive) in MCC. For this reason, we proposed a novel eye-based "immunoscore" model, obtained by tumor infiltrating lymphocytes subtyping (CD3, CD8, FoxP3, and PD-L1) that could provide additional prognostic information in Merkel cell carcinoma.
Collapse
Affiliation(s)
- C Ricci
- Department of Biomedical and Neuromotor Sciences, Section of Anatomic Pathology "M. Malpighi", Bellaria Hospital, 40139, Bologna, Italy
| | - A Righi
- Department of Pathology, Rizzoli Institute, 40136, Bologna, Italy
| | - F Ambrosi
- Department of Biomedical and Neuromotor Sciences, Section of Anatomic Pathology "M. Malpighi", Bellaria Hospital, 40139, Bologna, Italy
| | - D Gibertoni
- Department of Biomedical and Neuromotor Sciences, Unit of Hygiene and Biostatistics, University of Bologna, 40126, Bologna, Italy
| | - F Maletta
- Department of Oncology, University of Turin at Città della Salute Hospital, 10124, Turin, Italy
| | - S Uccella
- Unit of Pathology, Department of Medicine and Surgery, University of Insubria, 21100, Varese, Italy
| | - F Sessa
- Unit of Pathology, Department of Medicine and Surgery, University of Insubria, 21100, Varese, Italy
| | - S Asioli
- Department of Pathology, Morgagni-Pierantoni Hospital, 47121, Forlì, Italy
| | - M Pellilli
- Unit of Pathology, Department of Medicine and Surgery, University of Insubria, 21100, Varese, Italy
| | - R Maragliano
- Unit of Pathology, Department of Medicine and Surgery, University of Insubria, 21100, Varese, Italy
| | - S La Rosa
- Service of Clinical Pathology, Institute of Pathology, Lausanne University Hospital and University of Lausanne, CH-1011, Lausanne, Switzerland
| | - M G Papotti
- Department of Oncology, University of Turin at Città della Salute Hospital, 10124, Turin, Italy
| | - S Asioli
- Department of Biomedical and Neuromotor Sciences, Section of Anatomic Pathology "M. Malpighi", Bellaria Hospital, 40139, Bologna, Italy.
| |
Collapse
|
44
|
Chiaravalli A, Carnevali I, Sahnane N, Leoni E, Furlan D, Berselli M, Sessa F, Tibiletti M. Universal screening to identify Lynch syndrome: two years of experience in a Northern Italian Center. Eur J Cancer Prev 2019; 29:281-288. [DOI: 10.1097/cej.0000000000000543] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
45
|
Abstract
Metastatic cancer patients generally respond well to treatment with tyrosine kinase inhibitors (TKIs). However, TKI resistance occurs in almost all cases and often leads to a change in treatment. Recent guidelines, including thyroid cancer, raised the possibility of locally treating TKI-resistant oligoprogressive disease, i.e., one or a few progressing lesions in an otherwise treatment-responsive metastatic cancer, thereby obviating the need to change the ongoing TKI. To determine the benefits of this intervention, we reviewed studies on the use of LAT for TKI-treated oligoprogressive cancers. We found that in non-small cell lung cancer at least, LAT prolongs disease control and the duration of exposure to a TKI irrespective of the LAT used. Moreover, we reviewed the local ablative therapies (LATs) that are feasible for the local control of oligoprogressive thyroid cancer. Lastly, we report two illustrative cases of patients with oligoprogressive thyroid cancer treated with two different LATs while on therapy with TKIs. Both LATs extended the duration of disease control and the time of exposure to the ongoing TKI, thereby indicating that LAT is a favorable option for TKI-treated oligoprogressive thyroid cancer. Prospective randomized studies are needed to verify the benefit of LATs in terms of progression-free and overall survival in this increasingly frequent clinical setting.
Collapse
Affiliation(s)
- T Porcelli
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy.
| | - F Sessa
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy
| | - C Luongo
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy
| | - D Salvatore
- Department of Public Health, University of Naples "Federico II", Naples, Italy
| |
Collapse
|
46
|
Carnevali I, Riva C, Chiaravalli AM, Sahnane N, Di Lauro E, Viel A, Rovera F, Formenti G, Ghezzi F, Sessa F, Tibiletti MG. Inherited cancer syndromes in 220 Italian ovarian cancer patients. Cancer Genet 2019; 237:55-62. [PMID: 31447066 DOI: 10.1016/j.cancergen.2019.06.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2019] [Revised: 05/20/2019] [Accepted: 06/10/2019] [Indexed: 01/06/2023]
Abstract
BACKGROUND A subsets of ovarian carcinomas (OCs) are related to inherited conditions including Hereditary Breast and Ovarian Cancers (HBOC) and Lynch Syndrome (LS). The identification of inherited conditions using genetic testing might be a strategic model for cancer prevention that include benefits for the ovarian cancer patients and for their family members. METHODS We describe a retrospective Italian experience for the identification of inherited conditions in 232 patients affected by OCs using both somatic and germline analyses. RESULTS Immunohistochemical and microsatellite analyses performed on OCs identified 20 out of 101 MMR defective cancers and 15 of these were from patients carriers of the MMR germline pathogenetic variants. BRCA1 and BRCA2 testing offered to 198 OC patients revealed 67 (34%) pathogenetic variant carriers of BRCA1/2 genes. Interestingly LS patients revealed a mean age of OC onset of 45.4 years, which was significantly lower than the mean age of OCs onset of HBOC patients. CONCLUSIONS Somatic and germline analyses offered to OC patients has proved to be an efficient strategy for the identification of inherited conditions involving OC also in absence of suggestive family histories. The identification of LS and HBOC syndromes through OC patients is an effective tool for OC prevention.
Collapse
Affiliation(s)
- I Carnevali
- Department of Pathology, Ospedale di Circolo, ASST-Sette Laghi, Via O. Rossi 9, 21100 Varese, Italy; Research Center for the Study of Hereditary and Familial Tumors, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
| | - C Riva
- Research Center for the Study of Hereditary and Familial Tumors, Department of Medicine and Surgery, University of Insubria, Varese, Italy; Department of Medicine and Surgery, University of Insubria, Varese, Italy
| | - A M Chiaravalli
- Department of Pathology, Ospedale di Circolo, ASST-Sette Laghi, Via O. Rossi 9, 21100 Varese, Italy; Research Center for the Study of Hereditary and Familial Tumors, Department of Medicine and Surgery, University of Insubria, Varese, Italy
| | - N Sahnane
- Research Center for the Study of Hereditary and Familial Tumors, Department of Medicine and Surgery, University of Insubria, Varese, Italy; Department of Medicine and Surgery, University of Insubria, Varese, Italy
| | - E Di Lauro
- Department of Pathology, Ospedale di Circolo, ASST-Sette Laghi, Via O. Rossi 9, 21100 Varese, Italy
| | - A Viel
- Unit of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, PN, Italy
| | - F Rovera
- Research Center for the Study of Hereditary and Familial Tumors, Department of Medicine and Surgery, University of Insubria, Varese, Italy; Breast Unit Ospedale di Circolo, ASST Settelaghi, Varese, Italy
| | - G Formenti
- Department of Obstetrics and Gynaecology, Ospedale F.Del Ponte, ASST Settelaghi, Varese, Italy
| | - F Ghezzi
- Research Center for the Study of Hereditary and Familial Tumors, Department of Medicine and Surgery, University of Insubria, Varese, Italy; Department of Obstetrics and Gynaecology, Ospedale F.Del Ponte, ASST Settelaghi, Varese, Italy
| | - F Sessa
- Research Center for the Study of Hereditary and Familial Tumors, Department of Medicine and Surgery, University of Insubria, Varese, Italy; Department of Medicine and Surgery, University of Insubria, Varese, Italy
| | - M G Tibiletti
- Department of Pathology, Ospedale di Circolo, ASST-Sette Laghi, Via O. Rossi 9, 21100 Varese, Italy; Research Center for the Study of Hereditary and Familial Tumors, Department of Medicine and Surgery, University of Insubria, Varese, Italy
| |
Collapse
|
47
|
Monda V, Villano I, Messina A, Valenzano A, Salerno M, Santo Signorelli S, Monda M, Russo V, Sessa F, Messina G. Aerobic exercise and Orexin A: role of sympathetic activity and redox system. J BIOL REG HOMEOS AG 2019; 33:587-592. [PMID: 30968680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Aerobic exercise is associated with the sympathetic activation evoking adaptive responses to sustain muscle engagement. Physical exercise can cause alterations in the cardiovascular activity and cellular stress may occur which could be marked by either heart rate (HR), or galvanic skin response (GSR). Moderate plasma levels of reactive oxygen species (ROS) are considered as health markers, absolving to important roles such as adaptive cellular responses to exercise. Orexin A, a hypothalamic peptide, causes a widespread stimulation of the sympathetic nervous system, playing a role in many physiological functions.
Collapse
Affiliation(s)
- V Monda
- Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - I Villano
- Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - A Messina
- Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - A Valenzano
- Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy
| | - M Salerno
- Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy
| | - S Santo Signorelli
- Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
| | - M Monda
- Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - V Russo
- Department of Ophthalmology. University of Foggia, Foggia, Italy
| | - F Sessa
- Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy
| | - G Messina
- Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy
| |
Collapse
|
48
|
Capece M, Cocci A, Russo G, Cito G, Giubilei G, Cacciamani G, Garaffa G, Falcone M, Timpano M, Tasso G, Sessa F, Campi R, Di Maida F, Cai T, Morelli G, Giammusso B, Verze P, Palmieri A, Ralph D, Mirone V, Mondaini N. Collagenase clostridium histolyticum for the treatment of Peyronie's disease: a prospective Italian multicentric study. Andrology 2018; 6:564-567. [PMID: 29733116 DOI: 10.1111/andr.12497] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2017] [Revised: 03/06/2018] [Accepted: 03/29/2018] [Indexed: 12/01/2022]
Affiliation(s)
- M. Capece
- Dipartimento di Neuroscienze e Scienze Riproduttive ed Odontostomatologiche; Universita degli Studi di Napoli Federico II; Napoli Italy
| | - A. Cocci
- Department of Urology; Azienda Ospedaliero Universitaria Careggi; Firenze Italy
| | - G. Russo
- Department of Urology; Universita degli Studi di Catania Scuola di Facolta di Medicina; Catania Italy
| | - G. Cito
- Department of Urology; Azienda Ospedaliero Universitaria Careggi; Firenze Italy
| | - G. Giubilei
- Department of Urology; Azienda USL Toscana centro Sede di Empoli; Empoli Italy
| | - G. Cacciamani
- Azienda Ospedaliera Universitaria Integrata Verona; Verona Italy
| | | | - M. Falcone
- Department of Urology; Azienda Ospedaliero Universitaria Citta della Salute e della Scienza di Torino; Torino Italy
| | - M. Timpano
- Department of Urology; Azienda Ospedaliero Universitaria Citta della Salute e della Scienza di Torino; Torino Italy
| | - G. Tasso
- Department of Urology; Azienda Ospedaliero Universitaria Careggi; Firenze Italy
| | - F. Sessa
- Department of Urology; Azienda Ospedaliero Universitaria Careggi; Firenze Italy
| | - R. Campi
- Department of Urology; Azienda Ospedaliero Universitaria Careggi; Firenze Italy
| | - F. Di Maida
- Department of Urology; Azienda Ospedaliero Universitaria Careggi; Firenze Italy
| | - T. Cai
- Department of Urology; Santa Chiara Hospital; Trento Italy
| | - G. Morelli
- Department of Urology; Università di Pisa; Pisa Italy
| | - B. Giammusso
- Department of Urology; Universita degli Studi di Catania Scuola di Facolta di Medicina; Catania Italy
| | - P. Verze
- Dipartimento di Neuroscienze e Scienze Riproduttive ed Odontostomatologiche; Universita degli Studi di Napoli Federico II; Napoli Italy
| | - A. Palmieri
- Dipartimento di Neuroscienze e Scienze Riproduttive ed Odontostomatologiche; Universita degli Studi di Napoli Federico II; Napoli Italy
| | - D. Ralph
- The Institute of Urology; London UK
| | - V. Mirone
- Dipartimento di Neuroscienze e Scienze Riproduttive ed Odontostomatologiche; Universita degli Studi di Napoli Federico II; Napoli Italy
| | - N. Mondaini
- Department of Urology; Ospedale Santa Maria Annunziata; Bagno a Ripoli Italy
| |
Collapse
|
49
|
Pinotti G, Cerutti R, Sahnane N, Lettig L, Albeni C, Tuzi A, Franzi F, Pastore A, Ogliari F, Sessa F, Furlan D. EGFR T790M detection in TKI-naïve NSCLCs carrying sensitive EGFR mutations. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
50
|
De Rosa S, Libera L, Magnoli F, Capella C, Sessa F, Chiaravalli AM. Erratum to: Abstracts : XXXI International Congress of the IAP and 28th Congress of the ESP. Virchows Arch 2017; 470:237. [PMID: 28083673 PMCID: PMC7608134 DOI: 10.1007/s00428-016-2054-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- S De Rosa
- Unit of Anatomical Pathology, Ospedale di Circolo, Varese, Italy.
| | - L Libera
- Department of Surgical and Morphological Sciences, University of Insubria, Varese, Italy
| | - F Magnoli
- Department of Surgical and Morphological Sciences, University of Insubria, Varese, Italy
| | - C Capella
- Department of Surgical and Morphological Sciences, University of Insubria, Varese, Italy
| | - F Sessa
- Department of Surgical and Morphological Sciences, University of Insubria, Varese, Italy
| | - A M Chiaravalli
- Unit of Anatomical Pathology, Ospedale di Circolo, Varese, Italy
| |
Collapse
|